Ambea as an investment
- Growing need
- Strong market position
- High quality and competence
- Substantial growth
- Balanced risk
- Attractive capital allocation
The share
Key figures FY 2025
16,039 MSEK
Net sales
1,535 MSEK
Adjusted EBITA
13%
Growth
9.6%
EBITA margin
News and press releases
Calendar
- Mar 112026-03-11 09:10DNB Carnegie Healthcare Conference in Stockholm
- Mar 262026-03-26 09:50DNB Carnegie Small & Medium Enterprises Conference in Oslo
- Apr 92026-04-09 08:00Silent period
- May 72026-05-07 07:00Interim Report First Quarter 2026
Reports
Year-end report January-December 2025
In the last quarter of the year, we continued investing strongly in growth through acquisitions and new operations as well as through developing our operating structure.
Annual report: Future-proof care
Annual report with quality & sustainability report 2024
CEO Mark Jensen about the year-end report January-December 2025
CEO Mark Jensen presents the report from Kung Saga, one of Nytida’s upper secondary schools for students with special needs.
IR Contact
Susanne Vogt
Head of IR, Reporting & Group Business Control
No matching results.
